CClinicalTrials.gg
CompletedNCT01429662Updated May 30, 2012

Modified Relaxation (MR) Technique for Treating Hypertension in Postmenopausal Women

A Phase 3 interventional study of Modified Relaxation (MR) and Lifestyle Education (LE) in Postmenopausal Syndrome and Hypertension, sponsored by Chiang Mai University. Completed at 1 site in Thailand. Open to female participants aged 45 Years to 65 Years. Per ClinicalTrials.gov, last updated 2012-05-30.

Sponsored by Chiang Mai University · Phase 3, Interventional, and Treatment

Phase
Phase 3
Study type
Interventional
Enrollment
429
Allocation
Randomized
Ages
45 Years to 65 Years
Sex
Female
01

Study summary

The purpose of this study is to demonstrate better effectiveness of modified relaxation (MR) technique over no MR for treating hypertension in Thai postmenopausal women.

Read the detailed description

Medical treatment of hypertension (HTN) in postmenopausal women is not very effective, as it requires co-operation and long-term commitment from the patients and their families. The medication itself may cause bothersome side effects and it can pose economic burden to the patients and the society. In contrast, lifestyle modifications, particularly relaxation technique, are less costly and relatively free of any side effects. Once the patients master the techniques, they can practice by themselves at home and at any time that is convenient to them. There is evidence from at least one RCT that the techniques are effective in reducing the systolic blood pressure (SBP) and diastolic blood pressure (DBP), even after a short practice of only two months.

In this study, the investigators propose a randomized control trial to examine the effectiveness of modified relaxation (MR) technique to control HTN in Thai postmenopausal women against a control group who practice no MR. Such a study in Thai population has not been done before. In addition, the investigators will extend the period of observation up to 16 weeks, to assess longer-term patients' compliance, and the effects of MR on BP.

02

Conditions studied

  • Postmenopausal Syndrome
  • Hypertension

Browse trials for

Keywords

  • postmenopause
  • hypertension
  • relaxation
  • SBP 140-159 mmHg
  • DBP 90-99 mmHg
  • stage 1 or mild hypertension
03

In context

Hypertension

6,689 studies on the registry are indexed under Hypertension; 964 are open to participants now.

This study's enrollment of 429 is above the median of 90 across 4,994 interventional studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

Chiang Mai University is the lead sponsor of 116 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Stage 1 essential hypertension, defined as a systolic blood pressure of 140-159 and/or DBP of 90-99 mmHg on two occasions at least 30 minutes apart.
  • Women who are able to attend follow visits as advised.

Exclusion criteria

Exclusion Criteria:

  • Women with systolic blood pressure (SBP) >160 mmHg or diastolic blood pressure (DBP) >100 mmHg.
  • Women who have other known causes of hypertension, such as renal diseases
  • Women who are using sedatives or tranquilizer,or antidepressant, or antihypertensive medication during the past 2 months prior to the study.
  • Have language or geographical barrier.
  • Do not give their informed consent.
  • Women who need to be prescribed HRT.
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
429 participants (actual)

Study arms

  • Sham comparator
    Lifestyle Education (LE)

    Lifestyle Education (LE) Participants in this group will receive conventional care and lifestyle education on dietary choice and exercise.

    Behavioral: Lifestyle Education (LE)

  • Experimental
    Modified Relaxation (MR)

    Modified Relaxation (MR) This technique intend to train participants in a group of 8-10 in only 1 session that lasts 60 minutes. After completing the training, participants will be given a hand-out on MR. They will be asked to practice MR at home once a day for 15-20 minutes during their leisure times, for at least 5 days a week during the whole 16 weeks of the study period.

    Behavioral: Modified Relaxation (MR)

Interventions

  • BehavioralModified Relaxation (MR)

    Modified Relaxation (MR) This technique intend to train participants in a group of 8-10 in only 1 session that lasts 60 minutes. After completing the training, participants will be given a hand-out on MR. They will be asked to practice MR at home once a day for 15-20 minutes during their leisure times, for at least 5 days a week during the whole 16 weeks of the study period.

    Also known as: Behavioral Relaxation

  • BehavioralLifestyle Education (LE)

    Participants in this group will receive conventional care and lifestyle education on dietary choice and exercise.

    Also known as: Lifestyle Modification

06

What researchers measure

Primary outcomes

  1. Changes in SBP.

    Measure the systolic blood pressure (SBP) after intervention at 1, 2 ,3 , and 4 months.

    Time frame: 16 weeks

Secondary outcomes

  1. Changes in DBP.

    Measure the diastolic blood pressure (DBP) after intervention at 1, 2 ,3 , and 4 months.

    Time frame: 16 weeks

  2. Continuation rate of MR practice.

    Measure the continuation rate of MR practice after 4 months of follow-up period.

    Time frame: 16 weeks

  3. Drop-out rates.

    Measure the drop-out rate after intervention at 1, 2, 3, and 4 months of follow-up period.

    Time frame: 16 weeks

  4. Numbers of subjects who require anti-hypertensive medication.

    Measure the numbers of subjects who require anti-hypertensive medication after intervention 4 months of follow-up period.

    Time frame: 16 weeks

07

Study locations

1 site
  • Mahasarakham Hospital
    Maha Sarakham, Northeast 44000, Thailand
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 30, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01429662
Lead sponsor
Chiang Mai University
Responsible party
Suprawita Saensak (PhD candidate (Clinical Epidemiology), Chiang Mai University) — Principal investigator
First posted
Sep 7, 2011
Start date
Aug 2011
Primary completion
Mar 2012
Completion
Mar 2012
Last update
May 30, 2012

Study contacts

Suprawita Saensak, PhDcandidate
principal investigator · PhD in Clinical Epidemiology Program, Faculty of Medicine, Chiang Mai University (Thailand)

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion